RxDoctor Payments Data

Mark Galland, MD

Sports Medicine · Raleigh, NCNPI 1689741894

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. Moximed, Inc accounts for 62.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $7,685, 4.1 times the $1,893 reported in 2019.

$12,294in general payments, 2019–2025

Across 25 payments — averaging $491.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Moximed, Inc$8K
  • Southtech Orthopedics$3K
  • Arthrex$1K
  • Zimmer Biomet$67
  • Johnson & Johnson$27

What the payments were for

  • Consulting fees$6,75055%
  • Travel & lodging$9187%
  • Food & beverage$3643%
  • Education$4,26235%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Moximed, Inc10$7,685
Southtech Orthopedics4$3,400
Arthrex8$1,115
Zimmer Biomet1$67
Johnson & Johnson2$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,294 in reported general payments places this provider in the 80th percentile of 158 sports medicine providers in North Carolina.

See all sports medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$167,333
Medicare patients
320
Services billed
7,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl18$59

Paid to pharmacies, not to this prescriber.

Other sports medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →